Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the investigators study is to look at the visual outcomes of Ranibizumab
injections in combination with photodynamic therapy for the treatment of neovascular
age-related macular degeneration.
Phase:
Phase 4
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre